Emily Shaffer, PA-C

Emily Shaffer practices at OHC - Oncology Hematology Care in Cincinnati, Ohio.

Emily Shaffer's NPI, 1346924081, was assigned on June 13, 2023. Emily Shaffer holds Ohio license 50.008049RX.

Emily Shaffer's primary practice is OHC - Oncology Hematology Care, at 5053 Wooster Rd, Cincinnati, OH 45226. The practice phone is (513) 751-2273.

Emily Shaffer's primary practice is OHC - Oncology Hematology Care in Cincinnati, Ohio. Emily Shaffer is also affiliated with Bethesda North Hospital. The medical group on file is OHC - Oncology Hematology Care. Dmand AI also links Emily Shaffer to 4 more hospitals and 1 group practice or clinic, each named with a free account. Emily Shaffer's employer is on file too: an imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Emily Shaffer practices, 7 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Emily Shaffer's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Emily Shaffer is licensed in Ohio.

CMS data shows 641 Medicare services from Emily Shaffer across 7 procedure codes in 2024, for 235 Medicare patients. Medicare paid $20,095 for them. Every service was in an office.

CMS counts 235 Medicare patients who saw Emily Shaffer in 2024. The largest group is 65 to 74, with 142 patients. 72% of them have high cholesterol, and 71% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Emily Shaffer's median patient age at 68, with 100% women.

In 2024, Emily Shaffer wrote 429 Medicare Part D claims for 175 patients. 90% of them were for generic drugs. CMS names the drug for 276 of them, across 12 drugs with 11 or more claims each, at $18,285 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

Emily Shaffer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 27 general payments to Emily Shaffer from 14 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 86% of the total. GlaxoSmithKline, LLC. paid the most, $142.